Sabra Health Care REIT (SBRA) Depreciation & Amortization (CF) (2011 - 2026)

Sabra Health Care REIT's Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $53.1 million for Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 22.16% year-over-year to $53.1 million in Q1 2026; TTM through Mar 2026 was $196.6 million, a 15.53% increase from a year earlier, with the FY2025 full-year figure at $187.0 million, up 10.24% from the prior year.
• Depreciation & Amortization (CF) rose to $53.1 million in Q1 2026 per SBRA's latest filing, from $51.4 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $53.1 million in Q1 2026 and bottomed at $41.7 million in Q2 2024.
• The 5-year median for Depreciation & Amortization (CF) is $44.1 million (2023), against an average of $45.9 million.
• Across the five-year window, Depreciation & Amortization (CF) declined 18.77% in 2024 and advanced 22.16% in 2026, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $49.9 million in 2022, then fell by 14.12% to $42.9 million in 2023, then fell by 1.32% to $42.3 million in 2024, then gained by 21.5% to $51.4 million in 2025, then rose by 3.36% to $53.1 million in 2026.
• Per Business Quant, the three latest SBRA Depreciation & Amortization (CF) figures stand at $53.1 million (Q1 2026), $51.4 million (Q4 2025), and $48.5 million (Q3 2025).